Von Willebrand disease in children: Diagnosis and management of a pediatric cohort in one single center in Argentina

Seminars in Thrombosis and Hemostasis

Volumn 37, Issue 5, 2011, Pages 560-567

  Bonduel, Mariana ^a   Frontroth, Juan Pablo ^a   Hepner, Mirta ^a   Sciuccati, Gabriela ^a   Feliu Torres, Aurora ^a   Pieroni, Graciela ^a  

^a Hospital Nacional de Pediatrý a   (Argentina)

Author keywords

children; desmopressin; von Willebrand disease

Indexed keywords

BLOOD CLOTTING FACTOR 8 CONCENTRATE; DESMOPRESSIN;

ADOLESCENT; ARGENTINA; ARTICLE; BLEEDING; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEMOSTASIS; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MOLECULAR BIOLOGY; PEDIATRICS; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SUBSTITUTION THERAPY; TREATMENT RESPONSE; VON WILLEBRAND DISEASE;

ADOLESCENT; ARGENTINA; CHILD; CHILD, PRESCHOOL; COAGULANTS; COHORT STUDIES; DEAMINO ARGININE VASOPRESSIN; FACTOR VIII; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; MALE; MUTATION; TREATMENT OUTCOME; VON WILLEBRAND DISEASES; VON WILLEBRAND FACTOR;

EID: 81755184039     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0031-1281043     Document Type: Article

References (26)

1. Sadler J E., Budde U, Eikenboom J C. et al, Working Party on von Willebrand Disease Classification. Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor. J Thromb Haemost 2006 4 10 2103-2114 (Pubitemid 44403432)
2. Werner E J., Broxson E H., Tucker E L., Giroux D S., Shults J, Abshire T C. Prevalence of von Willebrand disease in children: a multiethnic study. J Pediatr 1993 123 6 893-898 (Pubitemid 23353251)
3. Biss T T., Blanchette V S., Clark D S. et al. Quantitation of bleeding symptoms in children with von Willebrand disease: use of a standardized pediatric bleeding questionnaire. J Thromb Haemost 2010 8 5 950-956
4. Nichols W L., Hultin M B., James A H. et al. von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA). Haemophilia 2008 14 2 171-232 (Pubitemid 351343618)
5. Mannucci P M. How I treat patients with von Willebrand disease. Blood 2001 97 7 1915-1919 (Pubitemid 32239066)
6. Nolan B, White B, Smith J, O'Reily C, Fitzpatrick B, Smith O P. Desmopressin: therapeutic limitations in children and adults with inherited coagulation disorders. Br J Haematol 2000 109 4 865-869 (Pubitemid 30609770)
7. Allen G C., Armfield D R., Bontempo F A., Kingsley L A., Goldstein N A., Post J C. Adenotonsillectomy in children with von Willebrand disease. Arch Otolaryngol Head Neck Surg 1999 125 5 547-551 (Pubitemid 29220575)
8. Sutor A H. DDAVP is not a panacea for children with bleeding disorders. Br J Haematol 2000 108 2 217-227 (Pubitemid 30143632)
9. Jiménez-Yuste V, Prim M P., De Diego J I. et al. Otolaryngologic surgery in children with von Willebrand disease. Arch Otolaryngol Head Neck Surg 2002 128 12 1365-1368 (Pubitemid 35424666)
10. Revel-Vilk S, Schmugge M, Carcao M D., Blanchette P, Rand M L., Blanchette V S. Desmopressin (DDAVP) responsiveness in children with von Willebrand disease. J Pediatr Hematol Oncol 2003 25 11 874-879 (Pubitemid 37413837)
11. Sánchez-Luceros A, Meschengieser S S., Woods A I. et al. Biological and clinical response to desmopressin (DDAVP) in a retrospective cohort study of children with low von Willebrand factor levels and bleeding history. Thromb Haemost 2010 104 5 984-989
12. Bowman M, Riddel J, Rand M L., Tosetto A, Silva M, James P D. Evaluation of the diagnostic utility for von Willebrand disease of a pediatric bleeding questionnaire. J Thromb Haemost 2009 7 8 1418-1421
13. National Committee for Clinical Laboratory Standards (NCCLS). Collection, Transport, and Processing of Blood Specimens for Testing Plasma-Based Coagulation Assays: Approved Guideline. Publication H21A4.Wayne, PA NCCLS 2002
14. Frontroth J P., Hepner M, Sciuccati G, Feliú Torres A, Pieroni G, Bonduel M. Prospective study of low-dose ristocetin-induced platelet aggregation to identify type 2B von Willebrand disease (VWD) and platelet-type VWD in children. Thromb Haemost 2010 104 6 1158-1165
15. Lahiri D K., Nurnberger J I. Jr. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 1991 19 19 5444
16. Andrew M, Vegh P, Johnston M, Bowker J, Ofosu F, Mitchell L. Maturation of the hemostatic system during childhood. Blood 1992 80 8 1998-2005
17. Srivastava A, Rodeghiero F. Epidemiology of von Willebrand disease in developing countries. Semin Thromb Hemost 2005 31 5 569-576 (Pubitemid 41642571)
18. Rodeghiero F, Ruiz-Sáez A, Bolton-Maggs P H., Hayward C P., Nair S C., Srivastava A. Laboratory issues in bleeding disorders. Haemophilia 2008 14 Suppl 3 93-103 (Pubitemid 351722389)
19. Bujnicki H L., Sidonio R F., Moore C G. et al. Predictors of von Willebrand disease in children: a case control study. Blood 2010 116 712 (Abst)
20. Rodeghiero F, Tosetto A, Abshire T et al. ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders. J Thromb Haemost 2010 8 9 2063-2065
21. Favaloro E J., Thom J, Patterson D et al. Desmopressin therapy to assist the functional identification and characterisation of von Willebrand disease: differential utility from combining two (VWF:CB and VWF:RCo) von Willebrand factor activity assays? Thromb Res 2009 123 6 862-868
22. Lee C A., Hubbard A, Sabin C A. et al, ISTH-SSC sub-committee on VWF. Laboratory diagnosis of von Willebrand disease: results from a prospective and blind study in 32 laboratories worldwide using lyophilized plasmas. J Thromb Haemost 2010 9 220-222
23. Casais P, Carballo G A., Woods A I. et al. R924Q substitution encoded within exon 21 of the von Willebrand factor gene related to mild bleeding phenotype. Thromb Haemost 2006 96 2 228-230 (Pubitemid 44219393)
24. Federici A B., Mazurier C, Berntorp E et al. Biologic response to desmopressin in patients with severe type 1 and type 2 von Willebrand disease: results of a multicenter European study. Blood 2004 103 6 2032-2038 (Pubitemid 38326217)
25. Castaman G, Lethagen S, Federici A B. et al. Response to desmopressin is influenced by the genotype and phenotype in type 1 von Willebrand disease (VWD): results from the European Study MCMDM-1VWD. Blood 2008 111 7 3531-3539
26. Federici A B., Iorio A, Castaman G. Clinical efficacy and safety versus biological response to desmopressin (DDAVP) in inherited von Willebrand disease (VWD) types 1 and 2: Initial results from the International study group on DDAVP in VWD in a cohort of 229 patients. Blood 2010 116 238 (Abst)